This company seems to have been delisted
Reason: Acquired by Immedica
Last recorded trade on: April 16, 2025
Source: https://www.immedica.com/en/press/immedica-completes-acquisition-marinus-pharmaceuticals-inc-2299708
Reason: Acquired by Immedica
Last recorded trade on: April 16, 2025
Source: https://www.immedica.com/en/press/immedica-completes-acquisition-marinus-pharmaceuticals-inc-2299708
Marinus Pharmaceuticals
MRNS
£0.41
Share price
0.00%
Change (1 day)
-63.73%
Change (1 year)
Categories
Revenue for Marinus Pharmaceuticals (MRNS)
Revenue in 2024 (TTM): £24.47 Million
According to Marinus Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is £23.55 Million. In 2023 the company made a revenue of £24.32 Million an increase over the revenue in the year 2022 that were of £21.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Marinus Pharmaceuticals from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | £24.47 M | 0.62% |
| 2023 | £24.32 M | 15.5% |
| 2022 | £21.05 M | 85.25% |
| 2021 | £11.36 M | 801.94% |
| 2020 | £1.26 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 AcelRx Pharmaceuticals
ACRX | £0.48 M | -97.93% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | £0.19 B | 718.51% | 🇺🇸 USA |
 Endo International
ENDPQ | £1.50 B | 6,292.67% | 🇮🇪 Ireland |
 Supernus Pharmaceuticals
SUPN | £0.50 B | 2,022.92% | 🇺🇸 USA |